Callan JMB Inc. (CJMB)

NASDAQ: CJMB · Real-Time Price · USD

5.16

-0.01 (-0.19%)

At close: Jul 18, 2025, 4:00 PM

5.59

+0.43 (8.33%)

After-hours: Jul 18, 2025, 4:06 PM EDT

-0.19% (1D)

Market Cap	22.93M
Revenue (ttm)	6.22M
Net Income (ttm)	-3.45M
Shares Out	4.44M
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,870
Open	5.30
Previous Close	5.17
Day's Range	5.16 - 5.38
52-Week Range	3.38 - 7.76
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 15, 2025

About CJMB

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes manag... [Read more]

Industry Integrated Freight & Logistics

Sector Industrials

IPO Date Feb 5, 2025

Employees 38

Stock Exchange NASDAQ

Ticker Symbol CJMB

Website https://callanjmb.com

Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding

Contract Increase Extends Seven-Year Partnership through June 2026 with Price Increase of $1.5 Million to Total Value of $9.1 Million

1 day ago - GlobeNewsWire

Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines

Callan JMB redistributed more than 1,300 vaccine doses using its specialized cold chain reusable shippers from Westside CDC in Chicago to Texas and New Mexico, ensuring no vaccines went to waste

6 weeks ago - GlobeNewsWire

Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update

Completed Initial Public Offering (IPO) on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option

2 months ago - GlobeNewsWire

Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs

Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency pre...

3 months ago - GlobeNewsWire

Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option

4 months ago - GlobeNewsWire

Callan JMB to Participate in Upcoming March Conferences

SPRING BRANCH, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergen...

4 months ago - GlobeNewsWire

Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations

SPRING BRANCH, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergenc...

5 months ago - GlobeNewsWire

Callan JMB Announces Partial Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering

SPRING BRANCH, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency ma...